Methylene Blue Explained – Benefits, Risks, and What Clinicians Need to Know
In this video, consultant psychiatrist Dr Sanil Rege explains the science behind Methylene Blue MAOI Effects, clarifying why a compound marketed as a cognitive enhancer functions as a potent monoamine oxidase inhibitor. Drawing on pharmacology and clinical evidence, he details how low doses inhibit MAO-A, amplify serotonin release, and interact with common antidepressants – creating a significant serotonin syndrome risk when combined with SSRIs, SNRIs, tramadol, dextromethorphan, or certain antihistamines.
Dr Rege also outlines the drug’s side-effect profile, its impact on haemoglobin, and the subtle grain of truth driving its hype in inflammation and oxidative stress. This video provides a clear, clinically grounded breakdown for psychiatrists, clinicians, and informed patients navigating methylene blue safely and thoughtfully.
Enhance Your Psychiatry Practice
Join The Academy by Psych Scene and earn CME & CPD points from 150+ hours of expert-led psychiatry courses. Hub Pro Included ✅
Check out our courses
KEY TAKEAWAYS
- Methylene blue is a highly potent MAO-A inhibitor, approximately 100 times stronger than moclobemide at low doses.
- Combining methylene blue with serotonergic agents can precipitate serotonin syndrome, including agitation, tremor, clonus, fever, and confusion.
- MAOI mechanisms produce rapid and strong effects by increasing stored intracellular serotonin, making toxicity more likely than with SSRIs.
- Side effects include methemoglobinemia, nausea, dizziness, headaches, and blue discolouration, even when the compound is used alone.
- Despite hype regarding cognition and anti-inflammatory benefits, methylene blue requires MAOI-level clinical caution, thorough medication checks, and explicit patient education.
Clinicians seeking deeper insight into MAO inhibition and antidepressant safety may find the ‘Mastering the Classics With Dr Gillman: Unlocking the Potential of MAOIs and TCAs in Modern Psychiatry‘ course valuable. In this course, Dr Ken Gillman provides an in-depth examination of MAOI mechanisms, contraindications, drug interactions, and practical prescribing strategies—directly reinforcing the pharmacological considerations highlighted in this video.
Subscribe to Psychiatry Simplified, our YouTube channel, for more videos on psychiatry, neuroscience, and mental health.
Get Serious About Psychiatry Learning
Our courses offer practical knowledge and clinical expertise at exceptional value, plus CME & CPD points.
Go to Academy by Psych Scene